国际脑血管病杂志
國際腦血管病雜誌
국제뇌혈관병잡지
INTERNATIONAL JOURNAL OF CEREBROVASCULAR DISEASES
2010年
6期
417-422
,共6页
脑出血%华法林%抗凝药%凝血因子类%因子Ⅶa%维生素 K
腦齣血%華法林%抗凝藥%凝血因子類%因子Ⅶa%維生素 K
뇌출혈%화법림%항응약%응혈인자류%인자Ⅶa%유생소 K
Cerebral hemorrhage%Warfarin%Anticoagulants%Blood coagulation factors%Factor Ⅶa%Vitamin K
华法林相关性脑出血发病率逐渐升高,早期病死率高达50%.危险因素包括高龄、国际标准化比率>3.5、高血压、卒中史、白质疏松、淀粉样脑血管病、伴随抗血小板治疗等.预后较差,尚无最佳治疗.
華法林相關性腦齣血髮病率逐漸升高,早期病死率高達50%.危險因素包括高齡、國際標準化比率>3.5、高血壓、卒中史、白質疏鬆、澱粉樣腦血管病、伴隨抗血小闆治療等.預後較差,尚無最佳治療.
화법림상관성뇌출혈발병솔축점승고,조기병사솔고체50%.위험인소포괄고령、국제표준화비솔>3.5、고혈압、졸중사、백질소송、정분양뇌혈관병、반수항혈소판치료등.예후교차,상무최가치료.
The incidence of warfarin-associated intracerebral hemorrhage is increasing gradually. Its early mortality is as high as 50%. The risk factors include advanced age, international normalized ratio > 3.5, hypertension, previous stroke, leukoaraiosis, cerebral amyloid angiopathy, and concomitant antiplatelet therapy, etc. Its prognosis was poor and there is no optimal treatment.
